About Dr. Miller

Jeremiah Miller, MD, FAAD, grew up in GA. After his freshman year at Wheaton College, he transferred to the University of Georgia where he graduated from the Honors Program. He earned his MD at the Medical College of Georgia and completed his internship in Chattanooga, TN. As a dermatology resident at the University of California, San Diego, he was trained and mentored by some of the premier dermatologists in the world. He was selected by his faculty and peers to be Chief Resident during his final year of residency.

Dr. Miller has published papers in numerous dermatology journals including the Journal of the American Academy of Dermatology and the British Journal of Dermatology and has presented research at the Society for Investigative Dermatology.

He is very grateful to have his practice in the center of Greenville so that he can treat patients within the community he calls home.

He and his staff appreciate that you are giving us the privilege to care for you.

Board Certification – American Board of Dermatology

Residency in Dermatology – University of California, San Diego

Internship – University of Tennessee, Chattanooga

Medical School – Medical College of Georgia

Undergraduate Education – BA, English, University of Georgia

Professional Memberships

• Fellow of the American Academy of Dermatology
• Board Certified by the American Board of Dermatology

Publications

• Coda AB, Hata T, Miller J, Audish D, Kotol P, Two A, Shafiq F, Yamasaki K, Harper JC, Del Rosso JQ, Gallo RL. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol. 2013 Oct;69(4):570-7. Link to article
• Hata TR, Afshar M, Miller J, Two AM, Kotol P, Jackson M, Alexandrescu DT, Kabigting F, Gerber M, Lai Y, Gallo RL. Etanercept decreases the innate immune wounding response in psoriasis. Exp Dermatol. 2013 Sep;22(9):599-601.
• Hata T, Audish D, Kotol P, Kabigting F, Coda A, Miller J, Alexandrescu D, Boguniewicz M, Taylor P, Aertker L, Kesler K, Hanifin J, Leung D, Gallo R, “A randomized controlled double blind investigation of the effects of Vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol. 2013 May 3.
• Afshar M, Kotol P, Miller J, Gallo R, Hata T. “The effect of pimecrolimus on innate immunity in atopic dermatitis subjects: a double-blind, randomized, vehicle-controlled study.” Br J Dermatol. 2013 Feb;168(2):426-8.
• Jacob S, Miller J, Herro E. “Atopic Dermatitis- A Historical Review.” Supplement to Skin and Aging. 2011 Jan; 3-10.
• Hata et al, “History of Eczema Herpeticum is associated with the inability to induce HBD-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis,” Br J Dermatol. 2010 Sep; 163 (3):659-61.
• Wharton J, Roffwarg D, Miller J, Sheehan DJ. “Cutaneous marginal zone lymphoma arising in the setting of erythema ab igne.” J Am Acad Dermatol. 2010 Jun;62(6):1080-1.
• Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. 'Pyoderma Gangrenosum: a Review and Update on New Therapies.” J Am Acad Dermatol. 2010 Apr;62(4):646-54.
• Miller J, Gallo R. “Vitamin D and Innate Immunity” Dermatol Ther. 2010 Jan;23(1):13-22.
• Ferris DG, Waller JL, Miller J, Patel P, Jackson L, Price GA, Wilson C. “Correlates of HPV Vaccine Acceptance by Men.” Journal of the American Board of Family Medicine. 2009 Jan-Feb;22(1):34-42.
• Ferris DG, Waller JL, Miller J, Patel P, Jackson L, Price GA, Wilson C. “Men’s Attitudes Toward Receiving the HPV Vaccine.” Journal of Lower Genital Tract Disease. 2008 Oct; 12(4).

Oral Presentations

• “Intravascular Histiocytosis” Aug 26, 2012. Pacific Dermatology Association, Huntington Beach, CA.
• “Effects of Etanercept on LL-37 and TLR9 expression in Psoriasis.” Society of Investigative Dermatology Annual Meeting, Phoenix, AZ, May 6, 2011.
• “Vitamin D Background and Significance” University of California San Diego Dermatology Grand Rounds. Dec. 10, 2009.